phase readout
saveNCT07419880: Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Fudan University. Phase: PHASE2. Conditions: Triple -Negative Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that